Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
Swiss pharmaceutical giant Novartis said on Thursday it had boosted its stake in biopharmaceutical firm Speedel by 51.7% and aimed to buy it out completely for 907 million Swiss francs (€560 millions, $882 million).
Novartis added the 51.7% to its existing 9.7 stake in Speedel for 130 Swiss francs cash per share, it said in a statement. The $882 million figure is what Novartis expects to pay for the entire acquisition of Speedel, including its initial 9.7% stake. (Economic Times)